BC Global Opportunities IX LP - 04 Sep 2025 SCHEDULE 13G Report for BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT)

Filing Manager
BC Global Opportunities IX LP
Reporting Manager
BC Global Opportunities IX LP
Security
BridgeBio Oncology Therapeutics, Inc. Common Stock
Symbol
BBOT
Shares outstanding
79,377,218 shares
Disclosed Ownership
4,365,747 shares
Ownership
5.5%
Form type
SCHEDULE 13G
Filing time
03 Sep 2025, 15:05:41 UTC
Date of event
04 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BC Global Opportunities IX LP 5.5% 4,365,747 0 4,365,747 Freeman Szeto Operation Manager
BC General Partner, LP 5.5% 4,365,747 0 4,365,747 Freeman Szeto Operation Manager
BC Capital Management Limited 5.5% 4,365,747 0 4,365,747 Freeman Szeto Operation Manager
Tan Kuangming 5.5% 4,365,747 0 4,365,747 Tan Kuangming Director